CRNX Form 144: 4,434 Shares Filed for Sale

Morgan Stanley Smith Barney LLC reported a Form 144 notice for sale of 4,434 shares of Common Stock of CRNX tied to exercise of stock options on 04/13/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC reported a Form 144 notice for sale of 4,434 shares of Common Stock of CRNX tied to exercise of stock options on 04/13/2026. The filing also lists prior 10b5-1 sales by Jeff Knight: 85,163 shares on 04/08/2026 and 9,911 shares on 03/16/2026, with proceeds shown in the filing.

Insights

Securities Compliance Analyst

Routine Form 144 sale notices and broker handling; no new claims of misconduct.

The filing lists a broker/dealer (Morgan Stanley Smith Barney LLC) handling 4,434 shares sold following an option exercise on 04/13/2026. It also documents prior 10b5-1 dispositions by Jeff Knight totaling 95,074 shares across two dates, with dollar proceeds recorded.

These entries are administrative notifications required under resale rules; cash‑flow recipients are the selling parties as shown. Further disclosure in subsequent SEC submissions would clarify timing and remaining holdings.

Key Figures

Broker-handled sale: 4,434 shares 10b5-1 sale: 85,163 shares 10b5-1 sale: 9,911 shares +1 more

4 metrics

Broker-handled sale 4,434 shares Exercise of stock options on 04/13/2026

10b5-1 sale 85,163 shares Jeff Knight sale on 04/08/2026, proceeds $3,414,701.10

10b5-1 sale 9,911 shares Jeff Knight sale on 03/16/2026, proceeds $370,411.47

Aggregate prior sales (listed) 95,074 shares Sum of two Jeff Knight 10b5-1 dispositions shown in filing

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"04/13/2026 | Exercise of Stock Options | Issuer"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/13/2026 - 04:36 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001881007
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Crinetics Pharmaceuticals, Inc.
SEC File Number	001-38583
Address of Issuer	6055 Lusk Boulevard San Diego CALIFORNIA 92121
Phone	8584506464
Name of Person for Whose Account the Securities are To Be Sold	JEFF KNIGHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4434	174876.96	104705330	04/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/13/2026	Exercise of Stock Options	Issuer			4434	04/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	04/08/2026	85163	3414701.10
JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	03/16/2026	9911	370411.47

144: Remarks and Signature

Remarks
Date of Notice	04/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeff Knight
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)